- Healthy interest coverage ratio of 15.7x
- Lower volatility than the market (beta 0.25)
- Low bankruptcy risk (Altman Z-Score: 90.57)
Benitec Biopharma Limited stock downgraded from Hold/Accumulate to Sell Candidate after Monday trading session
(Updated on Jul 27, 2026)
The Benitec Biopharma Limited stock price gained 0.96% on the last trading day (Monday, 27th Jul 2026), rising from $11.47 to $11.58. During the last trading day the stock fluctuated 3.79% from a day low at $11.36 to a day high of $11.79. The price has fallen in 5 of the last 10 days and is down by -10.85% for this period. Volume fell on the last day by -86 thousand shares and in total, 65 thousand shares were bought and sold for approximately $756.95 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.29% during the next 3 months and, with a 90% probability hold a price between $11.84 and $15.18 at the end of this 3-month period.
BNTC Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, July 22, 2026, and so far it has risen 1.22%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Benitec Biopharma Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $11.80 and $12.24. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Benitec Biopharma Limited stock
Benitec Biopharma Limited finds support from accumulated volume at $11.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.430 between high and low, or 3.79%. For the last week the stock has had daily average volatility of 4.96%.
Benitec Biopharma Limited is oversold on RSI14 (13). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (BNTC) For The Upcoming Trading Day Of Tuesday 28th
For the upcoming trading day on Tuesday, 28th we expect Benitec Biopharma Limited to open at $11.58, and during the day (based on 14 day Average True Range), to move between $11.22 and $11.94, which gives a possible trading interval of +/-$0.725 (+/-6.47%) up or down from last closing price. If Benitec Biopharma Limited takes out the full calculated possible swing range there will be an estimated 6.47% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $11.56 (0.17%) than the resistance at $12.15 (4.92%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Benitec Biopharma Limited stock A Buy?
The Benitec Biopharma Limited stock holds several negative signals and despite the positive trend, we believe Benitec Biopharma Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-1.188
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 28, 2026 - $11.58 ( 0.0288%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
BNTC Performance
Trading levels for BNTC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 12.01 | 3.68% |
| R2 | 11.84 | 2.27% |
| R1 | 11.74 | 1.39% |
| Price | 11.58 | |
| S1 | 11.41 | -1.45% |
| S2 | 11.31 | -2.32% |
| S3 | 11.15 | -3.74% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 13.63 | 17.70% |
| R2 | 12.37 | 6.82% |
| R1 | 12.15 | 4.92% |
| Price | 11.58 | |
| S1 | 11.56 | -0.173% |
| S2 | 11.44 | -1.21% |
| S3 | 11.05 | -4.58% |
BNTC Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | May 25, 2018 | Jun 01, 2018 | Jun 08, 2018 | $0.0450 | 0.0071% |
FAQ
Click here for our free guide on how to buy Benitec Biopharma Limited Stock.
Buy BNTC